AstraZeneca PLC Operating Income

AstraZeneca PLC (AZNCF) currently reports a operating income of $14B as of December 2025. That compares with $10B in the prior-year period — up 34.5% year over year. Use the charts on this page to explore AstraZeneca PLC's operating income history and peer comparisons.

AstraZeneca PLC's operating income increased from $10B to $14B — a 34.5% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AstraZeneca PLC reported $14B in operating income as of December 2025. That compares with $10B in the prior-year period — up 34.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AstraZeneca PLC, and consider following AZNCF for alerts when major investors trade the stock.

AstraZeneca PLC is classified in the Healthcare sector. On operating income, it currently shows $14B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZNCF with unrelated industries.